缓慢输注低剂量氯胺酮较静脉推注减少令人困扰的副作用:一项双盲、双模拟、随机对照试验
本研究为前瞻性、随机、双盲、双模拟、安慰剂对照试验,纳入急诊科成人中重度疼痛(数字评分量表NRS≥5)患者,比较低剂量氯胺酮0.3 mg/kg经15分钟缓慢输注(SI)与1分钟静脉推注(IVP)的镇痛疗效和副作用发生率。主要终点为60分钟内出现任何精神感知副作用的比例。共59例完成研究。IVP组86.2%和SI组70.0%出现任何副作用(差异=16.2%,95%CI -5.4至37.8)。SI组中度及以上精神感知副作用大幅减少:IVP组75.9%报告中度及以上副作用,SI组为43.4%(差异=32.5%,95%CI 7.9至57.1)。IVP组幻觉多于SI组(IVP n=8,27.6%;SI n=2,6.7%;差异=20.9%,95%CI 1.8至43.4)。镇痛疗效无显著差异,60分钟时IVP和SI组的平均%SPID分别为39.9%和33.5%,差异6.5%(95%CI -5.8至18.7)。
要点
- 急诊成人中重度疼痛(NRS≥5)使用低剂量氯胺酮0.3 mg/kg时,15分钟缓慢输注较1分钟静脉推注显著减少中度及以上精神感知副作用(IVP组75.9% vs SI组43.4%,差异32.5%,95%CI 7.9至57.1)。
- 缓慢输注组幻觉发生率显著低于静脉推注组(IVP组27.6% vs SI组6.7%,差异20.9%,95%CI 1.8至43.4)。
- 两组任何副作用发生率无显著差异(IVP组86.2% vs SI组70.0%,差异16.2%,95%CI -5.4至37.8)。
- 镇痛疗效无显著差异:60分钟时平均%SPID在IVP组为39.9%、SI组为33.5%,差异6.5%(95%CI -5.8至18.7)。
- 大多数接受低剂量氯胺酮的患者无论缓慢输注还是静脉推注都会出现精神感知副作用。
适用人群与场景
- 急诊科成人患者,表现为中重度疼痛(数字评分量表NRS评分≥5)。
诊断标准与关键阈值
- 中重度疼痛定义为数字评分量表(NRS)评分≥5。
处置流程与药物剂量
- 低剂量氯胺酮0.3 mg/kg,经15分钟缓慢输注或经1分钟静脉推注,两种给药方式均可。
研究设计与关键结果
- 研究类型:前瞻性、随机、双盲、双模拟、安慰剂对照试验;样本量:59例完成研究;人群:急诊科成人中重度疼痛(NRS≥5)患者;干预与对照:低剂量氯胺酮0.3 mg/kg经15分钟缓慢输注(SI) vs 经1分钟静脉推注(IVP)。
- 主要终点:60分钟内出现任何精神感知副作用的比例,IVP组86.2% vs SI组70.0%,差异=16.2%(95%CI -5.4至37.8)。
- 关键次要终点:中度及以上精神感知副作用发生率,IVP组75.9% vs SI组43.4%,差异=32.5%(95%CI 7.9至57.1)。
- 幻觉发生率:IVP组27.6%(n=8) vs SI组6.7%(n=2),差异=20.9%(95%CI 1.8至43.4)。
- 镇痛疗效:60分钟时平均%SPID在IVP组为39.9%、SI组为33.5%,差异=6.5%(95%CI -5.8至18.7),无显著差异。
证据类型、等级与局限
- 证据类型:随机对照试验(双盲、双模拟、安慰剂对照)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于急诊科成人中重度疼痛(NRS≥5)患者,使用低剂量氯胺酮0.3 mg/kg时,15分钟缓慢输注较1分钟静脉推注可显著减少中度及以上精神感知副作用和幻觉,且镇痛效果相当。
- 临床医生应知晓,即使采用缓慢输注,大多数患者仍会出现精神感知副作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: We compared the analgesic efficacy and incidence of side effects when low-dose (0.3 mg/kg) ketamine (LDK) is administered as a slow infusion (SI) over 15 minutes versus an intravenous push (IVP) over 1 minute.
METHODS: This was a prospective, randomized, double-blind, double-dummy, placebo-controlled trial of adult ED patients presenting with moderate to severe pain (numerical rating scale [NRS] score ≥ 5). Patients received 0.3 mg/kg ketamine administered either as a SI or a IVP. Our primary outcome was the proportion of patients experiencing any psychoperceptual side effect over 60 minutes. A secondary outcome was incidence of moderate or greater psychoperceptual side effects. Additional outcomes included reduction in pain NRS scores at 60 minutes and percent maximum summed pain intensity difference (%SPID).
RESULTS: Fifty-nine participants completed the study. A total of 86.2% of the IVP arm and 70.0% of the SI arm experienced any side effect (difference = 16.2%, 95% confidence interval [CI] = -5.4 to 37.8). We found a large reduction in moderate or greater psychoperceptual side effects with SI administration-75.9% reported moderate or greater side effects versus 43.4% in the SI arm (difference = 32.5%, 95% CI = 7.9 to 57.1). Additionally, the IVP arm experienced more hallucinations (n = 8, 27.6%) than the SI arm (SI n = 2, 6.7%, difference = 20.9%, 95% CI = 1.8 to 43.4). We found no significant differences in analgesic efficacy. At 60 minutes, the mean %SPID values in the IVP and SI arms were 39.9 and 33.5%, respectively, with a difference of 6.5% (95% CI = -5.8 to 18.7).
CONCLUSION: Most patients who are administered LDK experience a psychoperceptual side effect regardless of administration via SI or IVP. However, patients receiving LDK as a SI reported significantly fewer moderate or greater psychoperceptual side effects and hallucinations with equivalent analgesia.
参考来源
- Clattenburg EJ, Hailozian C, Haro D, et al. Slow Infusion of Low-dose Ketamine Reduces Bothersome Side Effects Compared to Intravenous Push: A Double-blind, Double-dummy, Randomized Controlled Trial. Acad Emerg Med. 2018. PMID: 29645317. doi:10.1111/acem.13428
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。